US EditionMonopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
- Tech Inc reported fourth quarter and full year 2025 financial results, with revenue of $7.51M beating expectations by $235.31K. The company posted an EPS of-$0.01.
- As an AI-enabled InsurTech platform, the company operates a marketplace improving health insurance industry processes through vertical integration and automation. It serves brokers, Managing General Underwriter , and third-party administrators .
- CEO Tim Johnson and CFO Julia Qian led the Earnings Conference Call to discuss results. Full details appear in the Form 10-K filed with the SEC, available on the Investor Relations website.
- Streamlining underwriting, sales, and service processes remains a core operational focus for the firm. By removing friction, it improves efficiency for insurance companies, brokers, MGUs, and TPAs.
- Projections made pursuant to the Private Securities Litigation Reform Act of 1995 reflect current views on potential operational results. Management cautioned that forward-looking statements regarding growth strategies involve known and unknown risks and uncertainties.
44 Articles
44 Articles
Calidi Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent ...
Announced partnership with Australian CRO to accelerate initiation of CLD-401 clinical trialThe Company has received feedback from the FDA through Type D interactions, and the Company believes its manufacturing and analytical approaches for CLD-401 are in alignment with FDA guidance;…
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
WILMETTE, Ill., March 27, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced the fourth quarter and full-year 2025 financial results…
The Record
Financial PostiAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results
NEW YORK and TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results…
Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
SOUTH SAN FRANCISCO, Calif., March 27, 2026 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) ('Senti Bio”), a clinical-stage biotechnology company developing...
Coverage Details
Bias Distribution
- 55% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
